Tesaro just raised $90M through a underwritten public offering slightly more then Prima's $5M with no underwriters. They do have more than one candidate in clinical trials so therefore more support from the investment community.
They're in Phase 111 with Niraparb for maintenance therapy in patients who have platinum sensitive ovarian cancer.
Another to add to the list for those who want to keep tabs on the sector and do further research. You wouldn't get a holder bring that to the table would you rob. Better than reading/researching the regurgitated $1M ,holders not dumping,low volume bs posted on here imo.
can't be that bad!, page-14
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $436.3M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.3¢ | 30.0¢ | $960.6K | 3.161M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 188729 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 46153 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |